Format
Sort by

Send to

Choose Destination

Search results

Items: 18

1.

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study.

Pfister R, Cairns R, Erdmann E, Schneider CA; PROactive investigators.

Diabet Med. 2011 Oct;28(10):1206-12. doi: 10.1111/j.1464-5491.2011.03281.x.

PMID:
21388447
2.

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH; CARDS Investigators.

Am J Kidney Dis. 2009 Nov;54(5):810-9. doi: 10.1053/j.ajkd.2009.03.022. Epub 2009 Jun 21.

PMID:
19540640
3.

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA; PROactive Investigators.

Diabetes Care. 2007 Nov;30(11):2773-8. Epub 2007 Jul 31.

PMID:
17666462
4.

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM; PROactive Investigators.

J Am Coll Cardiol. 2007 May 1;49(17):1772-80. Epub 2007 Apr 16.

5.

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators.

Lancet. 2005 Oct 8;366(9493):1279-89.

PMID:
16214598
6.

Apparent food allergy.

Greaves E, Blades M, Borthwick LJ.

Br J Gen Pract. 1993 Feb;43(367):82. No abstract available.

7.

Experience with NovoPen, an injection device using cartridged insulin, for diabetic patients.

Walters DP, Smith PA, Marteau TM, Brimble A, Borthwick LJ.

Diabet Med. 1985 Nov;2(6):496-7.

PMID:
2951126
8.

Diabetic control with gliquidone--a short acting sulphonylurea.

Borthwick LJ, Wilson S.

Eur J Clin Pharmacol. 1984;26(4):475-9.

PMID:
6428917
9.

N-Acetyl-beta-D-glucosaminidase levels and the onset of diabetic microangiopathy.

Whiting PH, Ross IS, Borthwick LJ.

Ann Clin Biochem. 1983 Jan;20 Pt 1:15-9.

PMID:
6838142
10.

Ciclazindol: an oral agent with weight reducing properties and hypoglycaemic activity.

Lean ME, Borthwick LJ.

Eur J Clin Pharmacol. 1983;25(1):41-5.

PMID:
6352281
11.

Inappropriate antidiuretic hormone secretion in Wernicke's encephalopathy.

Cooles PE, Borthwick LJ.

Postgrad Med J. 1982 Mar;58(677):173-4. No abstract available.

12.

Diabetes mellitus. Through the ages.

Borthwick LJ.

Nurs Mirror. 1980 Oct 30;151(18):26-9. No abstract available.

PMID:
7001385
13.

Insulinopenia in impaired glucose tolerance preservation of insulin response to I.V. arginine and tolbutamide.

Monson JP, Borthwick LJ, Spathis GS, Bloom SR.

Acta Diabetol Lat. 1980 Jan-Mar;17(1):1-7.

PMID:
6998240
14.

N-Acetyl-beta-D-glucosaminidase levels and diabetic microangiopathy.

Whiting PH, Ross IS, Borthwick LJ.

Clin Chim Acta. 1979 Oct 1;97(2-3):191-5.

PMID:
487603
15.

Performance of home blood-glucose meters.

Ross IS, Borthwick LJ.

Lancet. 1979 Aug 4;2(8136):257-8. No abstract available.

PMID:
89376
16.

Performance of blood-glucose meters.

Borthwick LJ, Ross IS.

Lancet. 1979 Apr 28;1(8122):924. No abstract available.

PMID:
86689
17.

Oral hypoglycaemic agents.

Borthwick LJ, Stowers JM.

Practitioner. 1979 Mar;222(1329):358-66. No abstract available.

PMID:
450836
18.

Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.

Stowers JM, Borthwick LJ.

Drugs. 1977 Jul;14(1):41-56. Review. No abstract available.

PMID:
328260
Items per page

Supplemental Content

Loading ...
Write to the Help Desk